ML

Michelle Lavin

Trinity College Dublin, St. James's Hospital, Royal College of Physicians of Ireland, Royal College of Pathologists, Royal College of Surgeons in Ireland, University of Dublin Trinity College

Research areas: Medicine · Hematology · Platelet Disorders and Treatments · Hemophilia Treatment and Research · Blood Coagulation and Thrombosis Mechanisms

ORCID iD 0000-0003-2999-4216

About

Dr. Michelle Lavin is a Consultant Haematologist in the Irish National Coagulation Centre and a passionate advocate for women's health. Her research focuses on the impact of gynaecological bleeding in Women, Girls and Persons with the Potential to Menstruate (WGPPM).

She has served an as invited expert to multiple international clinical practice guidelines in the field of bleeding disorders. Dr. Lavin works with international patient advocacy groups on community generated research blueprints, highlighting current unmet patient needs. She was awarded the Eberhard Mannem Award in 2019 and the Irish Haemophilia Society Lifetime Achievement award in 2024.

Her work and expertise has resulted in multiple invited positions on international scientific & advocacy committees :

International Society on Thrombosis and Haemostasis [ISTH]
- Von Willebrand Factor Scientific SubCommittee past Co-Chair
- Women's Health Theme Leader
- Annual Congress Planning Committee member

European Association for Haemophilia and Allied Disorders [EAHAD]
- Chair Women and Girls with Bleeding Disorders working group

World Federation of Haemophilia
- Chair of the Von Willebrand Disease & Rare Bleeding Disorders Committee
- Member Medical Advisory Committee

International Federation for Obstetrics and Gynaecology [FIGO]
- Associate Member Menstrual Disorders and Health Related Impacts Committee

Through her clinical and research work Dr Lavin seeks to improve health care equity, access and care for WGPPM worldwide.

Employment

Education

Projects & Funding

Projects & funding information is unavailable.

Publications (77)